ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 Survival Outcomes and Characterization of Patients With mCSPC Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response

192 views
February 24, 2022
0 Comments
Login to view comments. Click here to Login